Photo from Diogo Martins Branco/LinkedIn
Sep 28, 2023, 17:51
Diogo Martins Branco: Meta-analysis of Ki-67 prognostic value after neoadjuvant endocrine therapy.
Quoting Diogo Martins Branco, Medical Oncologist at the European Society of Medical Oncology, on LinkedIn:
“Meta-analysis of Ki-67 prognostic value after neoadjuvant endocrine therapy: 12 studies of 7,897 women with ER+/HER2- early breast cancer. High Ki-67 was associated with worse recurrence-free survival and overall survival, confirming the strong prognostic value of this biomarker after neoadjuvant endocrine therapy.
These findings will better inform clinical trial design and clinical practice. Out in the European Journal of Cancer.”
Source: Diogo Martins Branco/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 22, 2024, 22:09
Nov 22, 2024, 21:56
Nov 22, 2024, 21:35
Nov 22, 2024, 21:11
Nov 22, 2024, 21:07
Nov 22, 2024, 20:44